JPRN-UMIN000010548已完成未知
Efficacy of Poststroke Intensive Rosuvastatin Treatment for Aortogenic Embolic Stroke (EPISTEME trial) - Efficacy of Rosuvastatin therapy for aortogenic embolic stroke
Department of Neurology, Juntendo Universiy School of Medicine0 个研究点目标入组 100 人开始时间: 2013年4月19日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients during pregnancy or lactation 2) Allergy against statin 3) Patients with coronary artery disease and requiring statin therapy 4) Patients with severe renal dysfunction or liver dysfunction 5) Patients undergoing cyclosporin therapy
研究者
相似试验
已完成
2 期
Effect of drug Rosuvastatin When given in addition to the existing treatment in patients of skin disease (chronic plaque psoriasis)CTRI/2023/02/049424Pt BD Sharma PGIMS Rohtak48
已完成
不适用
Standard versus intensive therApy by Rosuvastatin for lipiD loweringHyperlipemiaJPRN-UMIN000006796Department of Cardiovascular medicine, Saga University Faculty of Medicine100
进行中（未招募）
不适用
The efficacy and safety of a medicine containing the active substance rosuvastatiPatients with primary hypercholesterolemia and mixed dyslipidemia (type IIb)MedDRA version: 14.1Level: LLTClassification code 10020604Term: HypercholesterolemiaSystem Organ Class: 100000004861MedDRA version: 14.1Level: LLTClassification code 10071235Term: Combined hyperlipidemiaSystem Organ Class: 100000004861EUCTR2012-004799-21-CZKRKA CR, s. r. o.540
进行中（未招募）
1 期
The efficacy and safety of a medicine containing the active substance rosuvastatiEUCTR2012-004799-21-HUKRKA Magyarország Kft., Budapest610
进行中（未招募）
1 期
The efficacy and safety of a medicine containing the active substance rosuvastatiEUCTR2012-004799-21-SIKrka, d.d., Novo mesto540